The Company is a Korea-based company mainly engaged in the production and sale of pharmaceuticals. The Company is involved in the development and sale of drugs for degenerative disc disease (DDD), osteoarthritis, triple negative breast cancer (TNBC), Alzheimer s disease (AD) and type I diabetes. In addition, it also produces and sells drugs for animal and provides bio big data analysis services. The drugs for Animal include drugs for animal osteoarthritis, as well as animal anticancer, among others. The bio big data analysis services are provided by knowledge-based in silico drug discovery (KISDD) platform and Ensol trans-omics network system (ETONS). The Company was founded on February 20, 2001 and its shares are listed on KOREA NEW EXCHANGE(KONEX) on September 10, 2018.
Headquarters
51, Techno 10-Ro, Yuseong-Gu
Daejeon; Daejeon;
Contact Details: Purchase the Ensol Biosciences Inc. report to view the information.
Website: http://www.ensolbio.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service